Aclaris Therapeutics Inc
NASDAQ:ACRS
Aclaris Therapeutics Inc
NASDAQ:ACRS
Price:
5.12
USD
-3.94%
Market Closed
Market Cap:
$715.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
US |
|
G
|
Gladstone Capital Corp
NASDAQ:GLAD
|
US |
|
G
|
Grupo Nagoin SA de CV
BMV:EDUCA18
|
MX |
|
Husqvarna AB
F:HRZ0
|
SE |
|
I
|
Intel Corp
XHAN:INL
|
US |
|
Expro Group Holdings NV
NYSE:XPRO
|
NL |
|
MBIA Inc
NYSE:MBI
|
US |
Multiples-Based Value
The Multiples-Based Value for Aclaris Therapeutics Inc (ACRS) under the Base Case is hidden
USD.
Compared with the current market price of 5.12 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACRS Multiples-Based Value
LOCKED
